CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftmen but cyclosporine A is still required to reduce GVHD and morbidity

S. J. Noga, G. B. Vogelsang, A. Seber, J. M. Davis, K. Schepers, A. D. Hess, R. J. Jones

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)728-732
Number of pages5
JournalTransplantation proceedings
Volume29
Issue number1-2
DOIs
StatePublished - Jan 1 1997

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this